Status:
COMPLETED
Hypofractionated Radiotherapy for Lung Cancer
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this trial is to pilot reducing the duration of radiation treatment for lung cancer patients from 6 to 5 weeks using tomotherapy. Specific patient doses will be based on tumor volume be...
Eligibility Criteria
Inclusion
- Thoracic neoplasm requiring at lest 60 Gy conventional radiotherapy
Exclusion
- Prior bleomycin or gemcitabine chemotherapy
- Prior thoracic radiotherapy
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT00214123
Start Date
June 1 2004
End Date
December 1 2012
Last Update
December 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792